Efficacia e tollerabilita del Topiramato nella terapia aggiuntiva a lungo termine: Analisi ad interim dopo quattro anni di trattamento

Translated title of the contribution: Long term efficacy and tolerability of Topiramate add-on terapy: Interim analysis after four years treatment

R. Canger, G. Avanzini, A. Tartara, C. Durisotti, L. Guidolin, S. Binelli, L. Canafoglia, L. Sartori, P. Garofalo, F. Pozzi, V. Silenzi, D. Bertelletti, M. Di Fazio, E. Perucca

Research output: Contribution to journalArticlepeer-review

Abstract

In this open trial efficacy and tolerability of topiramate add-on long term administration have been evaluted in patients with uncontrolled epilepsy of any seizure type 67 patients from 4 Italian centres were studied. TPM was added-on four standard AED's. After TPM titration, a maintenance period with the optimal efficacy dose has been reached in 64 patients. After 3 years, the mean duration of treatment was 9,5 months (± 7,6 d.s), the mean dose of TPM was 274 (± 144) mg/day. The reduction of seizure frequency was obteined in 30% of patients; 75% reduction occurred in 14% and 8% was seizure-free. 19,4% of patients dropped-out for adverse events, 22,4% for inefficacy.

Translated title of the contributionLong term efficacy and tolerability of Topiramate add-on terapy: Interim analysis after four years treatment
Original languageItalian
Pages (from-to)105-107
Number of pages3
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number99
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Long term efficacy and tolerability of Topiramate add-on terapy: Interim analysis after four years treatment'. Together they form a unique fingerprint.

Cite this